May 28, 2021

Credit:
NIAID
It’s easy for people to overlook the importance of fast, reliable diagnostic tests in scientific research. Most often, ill patients focus on what treatment is available for them to recover. But without a timely and accurate diagnosis, physicians won’t know the most optimal treatment to provide. NIAID researchers are using metabolic biomarkers and biosignatures to distinguish Lyme disease from other diseases with similar symptoms, such as Southern Tick-Associated Rash Illness (STARI). Read more about Differentiating Lyme disease from STARI.